BACKGROUND: The prognostic implications of low QRS voltage on the electrocardiogram (ECG) in heart failure (HF) are not well characterized. METHODS: We manually measured and summed the QRS voltage in all 12 leads of the ECG (sumQRS) in two cohorts: (1) 415 patients with a low left ventricular ejection fraction followed up in a HF clinic ("clinic cohort") and (2) 100 subjects with advanced HF who had an ECG within 1 year preceding cardiac transplantation ("pretransplant cohort"). Low voltage was defined as the lowest quartile of the clinic cohort (sumQRS <12 mV) and its prevalence was compared in the two cohorts. The associations of low voltage with 1-year outcomes were assessed in the clinic cohort. RESULTS: In the clinic cohort, the frequency of low voltage was higher in New York Heart Association class 4 versus class 1-3 patients (34% vs 22% respectively, P = .04). The frequency of low voltage in the pretransplant cohort (47%) was twice that of the clinic cohort (24%, P < .001). After 1 year of follow-up in the clinic cohort, low ECG voltage was associated with a higher rate of death (14% vs 5%, P = .008) and the composite end point of death or HF hospitalization (35% vs 20%, P = .004). These associations persisted in multivariable analyses adjusting for important confounders. CONCLUSIONS: Low ECG voltage is a marker of the severity of HF and is a risk factor for adverse outcomes in patients with systolic HF at 1 year.
BACKGROUND: The prognostic implications of low QRS voltage on the electrocardiogram (ECG) in heart failure (HF) are not well characterized. METHODS: We manually measured and summed the QRS voltage in all 12 leads of the ECG (sumQRS) in two cohorts: (1) 415 patients with a low left ventricular ejection fraction followed up in a HF clinic ("clinic cohort") and (2) 100 subjects with advanced HF who had an ECG within 1 year preceding cardiac transplantation ("pretransplant cohort"). Low voltage was defined as the lowest quartile of the clinic cohort (sumQRS <12 mV) and its prevalence was compared in the two cohorts. The associations of low voltage with 1-year outcomes were assessed in the clinic cohort. RESULTS: In the clinic cohort, the frequency of low voltage was higher in New York Heart Association class 4 versus class 1-3 patients (34% vs 22% respectively, P = .04). The frequency of low voltage in the pretransplant cohort (47%) was twice that of the clinic cohort (24%, P < .001). After 1 year of follow-up in the clinic cohort, low ECG voltage was associated with a higher rate of death (14% vs 5%, P = .008) and the composite end point of death or HF hospitalization (35% vs 20%, P = .004). These associations persisted in multivariable analyses adjusting for important confounders. CONCLUSIONS: Low ECG voltage is a marker of the severity of HF and is a risk factor for adverse outcomes in patients with systolic HF at 1 year.
Authors: Pim van der Harst; Jessica van Setten; Niek Verweij; Georg Vogler; Lude Franke; Matthew T Maurano; Xinchen Wang; Irene Mateo Leach; Mark Eijgelsheim; Nona Sotoodehnia; Caroline Hayward; Rossella Sorice; Osorio Meirelles; Leo-Pekka Lyytikäinen; Ozren Polašek; Toshiko Tanaka; Dan E Arking; Sheila Ulivi; Stella Trompet; Martina Müller-Nurasyid; Albert V Smith; Marcus Dörr; Kathleen F Kerr; Jared W Magnani; Fabiola Del Greco M; Weihua Zhang; Ilja M Nolte; Claudia T Silva; Sandosh Padmanabhan; Vinicius Tragante; Tõnu Esko; Gonçalo R Abecasis; Michiel E Adriaens; Karl Andersen; Phil Barnett; Joshua C Bis; Rolf Bodmer; Brendan M Buckley; Harry Campbell; Megan V Cannon; Aravinda Chakravarti; Lin Y Chen; Alessandro Delitala; Richard B Devereux; Pieter A Doevendans; Anna F Dominiczak; Luigi Ferrucci; Ian Ford; Christian Gieger; Tamara B Harris; Eric Haugen; Matthias Heinig; Dena G Hernandez; Hans L Hillege; Joel N Hirschhorn; Albert Hofman; Norbert Hubner; Shih-Jen Hwang; Annamaria Iorio; Mika Kähönen; Manolis Kellis; Ivana Kolcic; Ishminder K Kooner; Jaspal S Kooner; Jan A Kors; Edward G Lakatta; Kasper Lage; Lenore J Launer; Daniel Levy; Alicia Lundby; Peter W Macfarlane; Dalit May; Thomas Meitinger; Andres Metspalu; Stefania Nappo; Silvia Naitza; Shane Neph; Alex S Nord; Teresa Nutile; Peter M Okin; Jesper V Olsen; Ben A Oostra; Josef M Penninger; Len A Pennacchio; Tune H Pers; Siegfried Perz; Annette Peters; Yigal M Pinto; Arne Pfeufer; Maria Grazia Pilia; Peter P Pramstaller; Bram P Prins; Olli T Raitakari; Soumya Raychaudhuri; Ken M Rice; Elizabeth J Rossin; Jerome I Rotter; Sebastian Schafer; David Schlessinger; Carsten O Schmidt; Jobanpreet Sehmi; Herman H W Silljé; Gianfranco Sinagra; Moritz F Sinner; Kamil Slowikowski; Elsayed Z Soliman; Timothy D Spector; Wilko Spiering; John A Stamatoyannopoulos; Ronald P Stolk; Konstantin Strauch; Sian-Tsung Tan; Kirill V Tarasov; Bosco Trinh; Andre G Uitterlinden; Malou van den Boogaard; Cornelia M van Duijn; Wiek H van Gilst; Jorma S Viikari; Peter M Visscher; Veronique Vitart; Uwe Völker; Melanie Waldenberger; Christian X Weichenberger; Harm-Jan Westra; Cisca Wijmenga; Bruce H Wolffenbuttel; Jian Yang; Connie R Bezzina; Patricia B Munroe; Harold Snieder; Alan F Wright; Igor Rudan; Laurie A Boyer; Folkert W Asselbergs; Dirk J van Veldhuisen; Bruno H Stricker; Bruce M Psaty; Marina Ciullo; Serena Sanna; Terho Lehtimäki; James F Wilson; Stefania Bandinelli; Alvaro Alonso; Paolo Gasparini; J Wouter Jukema; Stefan Kääb; Vilmundur Gudnason; Stephan B Felix; Susan R Heckbert; Rudolf A de Boer; Christopher Newton-Cheh; Andrew A Hicks; John C Chambers; Yalda Jamshidi; Axel Visel; Vincent M Christoffels; Aaron Isaacs; Nilesh J Samani; Paul I W de Bakker Journal: J Am Coll Cardiol Date: 2016-09-27 Impact factor: 24.094
Authors: Kristjan Norland; Gardar Sveinbjornsson; Rosa B Thorolfsdottir; Olafur B Davidsson; Vinicius Tragante; Sridharan Rajamani; Anna Helgadottir; Solveig Gretarsdottir; Jessica van Setten; Folkert W Asselbergs; Jon Th Sverrisson; Sigurdur S Stephensen; Gylfi Oskarsson; Emil L Sigurdsson; Karl Andersen; Ragnar Danielsen; Gudmundur Thorgeirsson; Unnur Thorsteinsdottir; David O Arnar; Patrick Sulem; Hilma Holm; Daniel F Gudbjartsson; Kari Stefansson Journal: Nat Commun Date: 2019-10-22 Impact factor: 14.919
Authors: M Yldau Van Der Ende; Tom Hendriks; Dirk J Van Veldhuisen; Harold Snieder; Niek Verweij; Pim Van Der Harst Journal: Sci Rep Date: 2018-04-11 Impact factor: 4.379
Authors: Hye-Bin Gwag; Su-Hyun Lee; Hyeon-Jun Kim; June-Soo Kim; Young-Keun On; Seung-Jung Park; Kyoung-Min Park Journal: Int J Environ Res Public Health Date: 2021-12-07 Impact factor: 3.390